[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100610074":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":33,"locations":24,"responsibleParty":42,"collaborators":24,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":24,"enrollmentInfo":53,"targetDuration":24,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":66,"overallStatus":68,"whyStopped":24,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":24},{"fullName":5,"class":6},"Women and Infants Hospital of Rhode Island","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Enalapril","EXPERIMENTAL","First-line anti-hypertensive treatment with enalapril",[13],"Drug: Enalapril",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard treatment","ACTIVE_COMPARATOR","First-line anti-hypertensive treatment with standard of care treatment",[19],"Other: Standard treatment",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG",[9],null,{"type":6,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"First-line anti-hypertensive treatment per standard of care",[15],[29],{"name":30,"affiliation":31,"role":32},"Alisse Hauspurg, MD","WOMEN AND INFANTS HOSPITAL-RHODE ISLAND","PRINCIPAL_INVESTIGATOR",[34,39],{"name":30,"role":35,"phone":36,"phoneExt":37,"email":38},"CONTACT","401-274-1122","47451","ahauspurg@carene.org",{"name":40,"role":35,"phone":24,"phoneExt":24,"email":41},"Crystal Ware, RN","cware@wihri.org",{"type":43,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100610074","phase-3-cardiovascular-protection-after-preeclampsia-with-enalapril-100610074",false,"NCT07222852","Cardiovascular Protection After Preeclampsia With Enalapril","CAPP-E","Inclusion Criteria:\n\n* Postpartum individuals\n* ≥18 years old\n* Hypertensive disorder of pregnancy\n* Enrolled in Women and Infants Hospital Hypertension Equity remote monitoring program.\n\nExclusion Criteria:\n\n* Maternal cardiac disease\n* Individuals with pre-pregnancy hypertension or diabetes\n* Allergy or contraindication to enalapril","FEMALE","18 Years",{"count":54,"type":55},60,"ESTIMATED","INTERVENTIONAL",[58],"PHASE3","The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.",[61,62,63,64,65],"Preeclampsia","Hypertensive Disorder of Pregnancy","Hypertension","Gestational Hypertension","Gestational Hypertension After Childbirth",[67],"postpartum hypertension, preeclampsia, gestational hypertension","NOT_YET_RECRUITING","2025-10-29",{"date":71,"type":72},"2025-10-30","ACTUAL",{"date":74,"type":55},"2025-11-15",{"date":76,"type":55},"2027-10-15",{"name":5,"class":6}]